Guidelines

New guidelines update VTE treatment recommendations

Publish date: January 8, 2016

 

FROM CHEST

References

msullivan@frontlinemedcom.com

Pages

Recommended Reading

Idarucizumab approved as first agent to reverse a novel oral anticoagulant
MDedge Cardiology
Mean platelet volume higher in DVT patients with PE than without
MDedge Cardiology
TCT: Immobilized leaflets on bioprosthetic aortic valves trigger concern
MDedge Cardiology
CHEST: Catheter-directed thrombolysis shows pulmonary embolism efficacy
MDedge Cardiology
FDA finds long-term clopidogrel does not increase death or cancer risks
MDedge Cardiology
Andexanet reverses anticoagulant effects of factor Xa inhibitors
MDedge Cardiology
AHA: DAPT score helps decide whether DAPT continues
MDedge Cardiology
FDA okays prophylactic Pradaxa for VTE in hip replacement
MDedge Cardiology
AHA: DAPT prevents migraines after atrial-septal defect closure
MDedge Cardiology
Study characterizes intracerebral hemorrhage with new oral anticoagulants
MDedge Cardiology